Brokerage firm Citigroup Maintains its rating on AmerisourceBergen Corp.(NYSE:ABC). In a research note issued to the investors, the brokerage major Raises the price-target to $105.00 per share. The shares have been rated Buy. The rating by Citigroup was issued on Aug 3, 2016.
In a different note, On Aug 3, 2016, Deutsche Bank said it Maintains its rating on AmerisourceBergen Corp.. In the research note, the firm Raises the price-target to $83.00 per share. The shares have been rated ‘Hold’ by the firm. On Jun 7, 2016, Bank of America said it Reinstates its rating on AmerisourceBergen Corp.. The shares have been rated ‘Neutral’ by the firm.
AmerisourceBergen Corp. (ABC) shares turned negative on Fridays trading session with the shares closing down -0.04 points or -0.04% at a volume of 13,19,515. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $89.19. The peak price level was also seen at $89.19 while the days lowest was $88.33. Finally the shares closed at $88.91. The 52-week high of the shares is $108.18 while the 52-week low is $73.31. According to the latest information available, the market cap of the company is $19,092 M.
AmerisourceBergen Corp.(ABC) last announced its earnings results on Aug 2, 2016 for Fiscal Year 2016 and Q3.Company reported revenue of $36.88B. Analysts had an estimated revenue of $36.58B. Earnings per share were $1.37. Analysts had estimated an EPS of $1.27.
Several Insider Transactions has been reported to the SEC. On Mar 3, 2016, Dale Danilewitz (Executive Vice President) sold 1,586 shares at $86.80 per share price.Also, On Dec 22, 2015, Steven H Collis (President & CEO) sold 27,148 shares at $102.23 per share price.On Dec 2, 2015, Dermot Mark Durcan (director) purchased 1,000 shares at $99.70 per share price, according to the Form-4 filing with the securities and exchange commission.
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company operates through two segments: Pharmaceutical Distribution and Other. The Company also provides data and other services to its manufacturing customers. The Company provides services to healthcare providers and pharmaceutical and biotech manufacturers. The Company provides pharmacy services to certain specialty drug patients. Additionally the Company offers healthcare providers and pharmaceutical manufacturers with services including reimbursement and pharmaceutical consulting services logistics services inventory management pharmacy automation and pharmacy management. The Company has a distribution facility network totaling approximately 30 distribution facilities in the United States.